Navigation Links
Stage II and stage III colon cancer patients treated after 1995 have improved overall survival
Date:6/3/2010

CHICAGO Patients with stage III colon cancer treated with 5-FU-based chemotherapy after complete surgical removal of their tumor after 1995 had improved overall survival with no change in time to recurrence compared to patients treated before 1995. In contrast, patients with stage II colon cancer treated after 1995 had longer time to recurrence and time from recurrence to death compared to those patients treated prior to 1995, according to Mayo Clinic and Gr Hospitalier Pitie-Salpetriere, Paris, researchers. They will present the study's findings on June 4-8, 2010, at the American Society of Clinical Oncology (http://www.asco.org/) annual meeting in Chicago.

"By combining information from 21 cancer treatment trials for patients with stage II and stage III colon cancer, our analysis determined that those patients treated after 1995 had improved overall survival," says Dan Sargent, Ph.D., Mayo Clinic biostatistician, North Central Cancer Treatment Group (http://ncctg.mayo.edu/) (NCCTG) statistician and senior author on the study.

The analysis compared patient data from more than 18,000 patients with stage II and stage III colon cancer treated with 5-FU-based chemotherapy after their primary tumor had been surgically removed for the time period 1978-1995 versus 1996-2007.

"Patients with stage II colon cancer treated after 1995 had had longer time to recurrence, possibly due to improvements in surgery and pathology" says Dr. Sargent. "In addition, after 1995, both stage II and stage III colon cancer patients treated after surgery with the same 5-FU-based chemotherapy after surgery had improved overall survival. This finding provides evidence to support previous findings that access to new medical therapies introduced in the mid-1990s as well as the expanded use of surgery for patients recurrent disease have meaningfully improving overall survival for patients treated in this setting."

The findings arise from analysis of combined data collected within an expanded database by the Adjuvant Colon Cancer End Points (ACCENT) Group, a consortium of scientists. The ACCENT database includes data from more than 33,500 patients from the United States, Canada, Australia and Europe. ACCENT, chaired by Dr. Sargent, is supported by the NCCTG.


'/>"/>

Contact: Karl Oestreich
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. THE COMPLETE PACKAGE NEW REALITY SHOW SETS STAGE AND NEW STANDARD
2. Translational Regenerative Medicine Forum sets stage for accelerating therapies to patients
3. Immune memory formation seen in early stages of viral infection
4. New Test Might Smell Early Stage Lung Cancer
5. Ultrasound plus proteomic blood analyses may help physicians diagnose early-stage ovarian cancer
6. Study finds racial disparities exist in radiation therapy rates for early stage breast cancer
7. Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer
8. Forests take center stage at Copenhagen
9. Diabetics Less Prone Now to End-Stage Kidney Disease
10. Too Many With End-Stage Dementia Get Feeding Tubes
11. MDS Announces Agreements to Divest MDS Pharma Services Early Stage Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... In ... reported skipping doses or not filling a prescription because they could not afford ... cost-related problems getting medications were 30-60%*. At the same time, hospitals, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Using the power ... utilizing a simple online checklist. Over a period of just 24 months, thousands of ... of an online checklist called T.A.D. , “The internet is not getting quieter. In ...
(Date:2/22/2017)... TX (PRWEB) , ... February 22, 2017 , ... ... the launch of ProGen™ PRP, the latest innovation in the delivery of Platelet ... wound care, aesthetics, cardiovascular and pain management, to accelerate tissue synthesis and provide ...
(Date:2/22/2017)... ... ... Super-Sod will attend the Athens Home Show with a brand new look during ... simple Athens Home Show booth of 2016, this year’s exhibit space includes recycled display ... constructed furniture from recycled pallet wood at the Super-Sod farm in Fort Valley, Georgia. ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... with so many different solutions on the market, it is easy to start ... Texas Premier Locksmith offers a complimentary security consultation. , Home Security Hardware ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... PORTLAND, Oregon and PUNE, India , February 22, 2017 ... that the global market was valued at $3,453 million in 2015 and is projected ... to 2022. The arthroscopic implants segment held nearly two-fifths of the total market in ... ... Allied Market Research Logo ...
(Date:2/22/2017)... , Feb. 22, 2017   Protein Sciences ... of Flublok® Influenza Vaccine , announced today that ... for Influenza Vaccine Introduction (PIVI) and the Mongolian Ministry ... impacts of the flu.  The doses of Flublok have ... Mongolia for health care workers, pregnant ...
(Date:2/22/2017)... Pharma announced today the completion of its executive management ... were added to form an executive team that will ... the implementation and administration of its newly executed strategic ... companies. Effective as of February ... following eight members reporting to Robert DiCrisci : ...
Breaking Medicine Technology: